Markets are digesting a fresh Fed rate hike with diverging moves across assets. Gold has reclaimed $4,300, Japanese equities face technical pressure, and selective biotech names are drawing attention.
Asian equities face crosscurrents as Chinese chipmakers gain on policy hopes, the Nikkei 225 tests technical limits, and U.S. rate expectations near 95% shift global capital flows.
U.S. Treasury yields are rising on hawkish Fed expectations, multiple Asian stocks are under pressure, and capital is rotating toward active strategies. Here’s what matters for your positions.